For example, IRE1 recruits TNF receptor associated factor 2 (TRAF2), and activates c-jun-N-terminal kinase (JNK), which inhibits the anti-apoptotic protein BCL212; conversely, IRE1 facilitates tumor cell growth in vivo by promoting the expression of β-catenin13. Here, TRAF2 is linked to neoplasm.